Services on Demand
- Cited by SciELO
- Access statistics
- Cited by Google
- Similars in SciELO
- Similars in Google
Print version ISSN 1413-8670
Braz J Infect Dis vol.16 no.1 Salvador Jan./Feb. 2012
Juan-Juan WangI,II; Yu-Feng LiII; Ying-Ying JinII; Xi WangII; Tong-Xin ChenI,*
IDepartment of Clinical Immunology/Department of Nephrology and Rheumatology, Children's Hospital of Shanghai, Shanghai Jiao Tong University, Shanghai, China
IIDepartment of Pediatrics, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
OBJECTIVE: Epstein-Barr virus (EBV) is a ubiquitous human γ-herpes virus, which can adapt and evade host immune defense. Dendritic cells (DCs) play a pivotal role in the initiation and maintenance of immune responses. This study investigated the effects of EBV on cord blood monocytes derived DCs (CBDC).
METHODS: Monocytes were isolated from cord blood and cultured in medium containing recombinant IL-4 and GM-CSF to induce DCs development. B95-8 supernatant was added in monocytes culture medium for EBV infection at day 0. Phenotypic characterization of DCs, apoptotic cells, and mitochondrial membrane potential (MMP) were detected by flow cytometry. The morphology was observed by Hoechst 33258 staining and TUNEL staining, the expression of X-linked inhibitor of apoptosis protein (XIAP) was detected by Western blotting assay and caspase 3, 8 and 9 activity was measured.
RESULTS: Phenotypic characterization of DCs was changed in EBV-treated group. Chromatin condensation and DNA fragmentation were observed in EBV induced CBDC apoptosis. In addition, caspase 3, caspase 8, and caspase 9 activation were enhanced in the EBV-treated group. This was accompanied by the loss of MMP. Furthermore, XIAP expression was down-regulated in the EBV-treated group and compared to mock-infected group.
CONCLUSION: These results suggested that EBV could inhibit CBDC phenotypic differentiation, and induce CBDC apoptosis in caspase-dependent manner with involvement of the mitochondrial pathway. This might help EBV to evade host immune responses to establish persistent infection.
Keywords: Dendritic cells; Apoptosis; Epstein-Barr virus infections
Epstein-Barr virus (EBV) is a ubiquitous human γ-herpes virus present in 90% of the world population. Primary EBV infection is usually asymptomatic at an early age. The infected individuals harbor the virus without further expression of clinical symptoms. Under certain conditions, EBV infections may also be associated with the development of malignancies, such as nasopharyngeal carcinomas, lymphoproliferative syndrome of immunocompromised patients and with some lymphomas (Burkitt's lymphoma, Hodgkin's lymphoma or T cell lymphoma).1,2
Dendritic cells (DCs) are antigen-presenting cells that play key roles in linking innate and adaptive immunity. DCs play a crucial role in anti-viral immune responses. DCs might also be involved in the immune escape mechanisms of EBV. The relationship between EBV and DCs remains unclear, although more and more evidence has accumulated. CD14+ monocytes can be induced to differentiate into DCs both in vitro and in vivo, indicating divergent pathways for monocytes differentiation.
The outcome of EBV infection is dependent on the monocyte maturation state. Recently, Li et al.3 have demonstrated that EBV infection inhibits the development of DCs by promoting apoptosis of their monocyte precursors cultured with granulocyte-macrophage colony-stimulating factor (GM-CSF) and IL-4. Thus, modulation of monocytes survival and maturation may represent an important strategy used by EBV to interfere with virus-specific immune responses.
Apoptosis plays an important role in host immune response to viral infection and is an efficient mechanism for killing infected cells containing virion spillage. Apoptosis will be favored by the virus to enhance virus fitness. Several experiments have shown that EBV is associated with altered regulation of cell differentiation or apoptosis.4 However, there are few reports concerning the activity of human cord blood dendritic cells (CBDC).
In this study, the potential of human CBDC, generated from umbilical cord blood monocytes in the presence of GM-CSF and IL-4, was analyzed. The results demonstrated that EBV could infect monocytes and inhibit their differentiation into DCs. EBV induced cell death in vitro, and the cell death was associated with nucleosomal cleavage of cellular DNA and expression of phosphatidylserines on cell surface, an early event of apoptosis occurring before membrane disruption. We demonstrated that EBV-induced apoptosis was dependent on activation of caspases. These findings might help us well understand the immunoregulation and pathogenesis of EBV infection.
Materials and methods
Isolation of monocytes
Human umbilical cord blood samples were collected from normal, full-term infants. Informed consent was obtained from the mothers prior to delivery. The protocol was approved by Institutional Review Board of Xinhua Hospital. All cord blood samples were collected in heparinized flasks. Cord blood mononuclear cells were isolated from whole blood using Ficoll-Hypaque gradients (Hengxin Chemical Reagent Co., Ltd, Shanghai, China). Mononuclear cells at the interface were collected, washed twice with PBS, then cells were plated at a density of 1×106 cells/mL in complete culture medium (RPMI 1640 supplemented with 10% heat-inactivated fetal calf serum, 2 mM L-glutamine, 1 mM sodium pyruvate, 10 mM Hepes, 100 U/mL penicillin and 100 U/mL streptomycin) on plastic plates and incubated at 37ºC, 5% CO2 for 2 hours. The adherent cells were detached with cell scraper. Cell viability, was measured using trypan blue exclusion. If viability was more than 95%, cells could be harvested. The purity of monocytes (CD14+ cells) was measured by flow cytometry. If purity was more than 90%, cells could be harvested.
Generation of immature DCs in vitro
Detached monocytes (1×106 cells/mL) were maintained in complete culture medium containing IL-4 (10 ng/mL, PeproTech, USA) and GM-CSF (50 ng/mL, PeproTech, USA) and incubated in a humidified incubator with 5% CO2 at 37ºC. The cultures were fed with fresh medium and cytokines every 3 days. Cell differentiation was monitored by light microscopy.
Virus preparation, titration and infection
EBV was obtained from culture supernatants of B95-8 cell line. Briefly, B95-8 cells were incubated in RPMI-1640 medium supplemented with 10% heat-inactivated fetal bovine serum. The viability of cells was determined by trypan blue-dye exclusion. When the viability reached 20% or less, the cell culture supernatant was harvested, and filtered through a 0.22 µm pore size filter. The virus was purified by ultracentrifugation at 16000xg for 90 min at 4ºC. Virus stocks were resuspended in RPMI-1640, aliquoted and frozen at -70ºC until use. EBV infection was performed by resuspending EBV preparation in 1×106 monocytes (1:2v/v). This was set as the 0 day point of infection (POI) for the experiments described below. After incubation for 1 h at 37ºC, cells were washed with PBS and cultured in medium contained IL-4 and GM-CSF to induce DCs development. Mock infected cells were treated in parallel, without virus.
After a 7-day culture as described above, cells were mixed with fluorochrome-conjugated antibodies (CD14-FITC, CD40-FITC, CD80-FITC, CD83-FITC, CD86-FITC, MHC class I-FITC, MHC class II-FITC, CD11c-PE, MR-PE, and CD1a-PC5, HLA-DR-PC5) at a concentration of 4 µg/106 cells and incubated in dark for 15 min. After incubation, cells were resuspended in 300 µL PBS and analyzed by flow cytometry (FACSCalibur, Becton Dickinson, USA). Control cells were stained with isotype-matched antibodies. The proportions of positive cells were calculated using CellQuest software. FITC, PE and PC5 conjugated antibodies were all from BD PharMingen (San Diego, CA, USA).
Apoptosis assay by flow cytometry
Cells were gently scraped and collected from the wells at the defined time. The percentage of cells undergoing apoptosis was detected by using the Annexin V (AV)-FITC Apoptosis Detection Kit (BioVision, USA). Cells were resuspended in 1×binding buffer at a concentration of 1×106 cells/mL. A volume of 100 µL of solution containing 1×105 cells was incubated with 5 µL of AV-FITC and 5 µL of propidium iodide (PI) for 15 min at room temperature in the dark, followed by addition of 400 µL of 1×binding buffer. Samples were analyzed by flow cytometry within 1 hour.
Measurement of nuclear morphology by Hoechst 33258 staining
Cells were harvested on day 7. Briefly, cells were fixed with 4% paraformaldehyde for 30 min and washed three times with PBS. Then cells were exposed to 10 mg/L Hoechst 33258 (Beyotime, China) in the dark at room temperature for 10 min. Morphologic changes in apoptotic nuclei were observed under fluorescence microscope with excitation at 350 nm and emission at 460 nm. The cells with condensed chromatin and shrunken nuclei were classic as apoptotic. The apoptotic percentage was calculated by counting the number of apoptotic cells in three different fields per slide. At least three slides were counted.
Measurement of DNA fragmentation using the TUNEL assay
To detect cells containing DNA fragments, the TUNEL (TdT-mediated dUTP nick-end labeling) method was employed. EBV-infected or mock-infected DCs were harvested on day 7 post infection. The FITC-labeled TUNEL-positive cells were stained with the One Step TUNEL Apoptotic Assay Kit (Beyotime, China) according to the manufacturer's instruction. All samples were detected by fluorescence microscope. Three randomly areas per slide were used to calculate the rate of apoptotic cells. At least three slides were counted.
Caspase 3, 8 and 9 activity assay
Caspase activity was determined on the basis of transformed ability of caspase 3, 8 and 9 (Beyotime, China). Cells were lysed in a lysis-buffer (100 µL per 2×106 cells ) for 15 min on ice. The cell lysate was centrifuged at 12000xg for 15 min at 4ºC and the precipitates were discarded. Protein concentrations were measured by the Bradford Protein Assay Kit (Beyotime, China). The mixture composed of 10 µL of cell lysate, 80 µL of reaction buffer and 10 µL of 2 mM caspase substrate (for -8,-9, and -3) was incubated in 96-well plate at 37ºC for 2 hours. Caspase activity was quantified by a microplate spectrophotometer (Biotek, USA) at 405 nm. The specific caspase activity, normalized for total proteins of cell lysate, was then expressed as fold of the baseline caspase activity of control cells.
Detection of XIAP by Western blot analysis
X-linked inhibitor of apoptosis protein (XIAP) was quantified by Western blotting analysis. Briefly, total proteins were prepared by standard procedures and quantified by Bradford Protein Assay Kit (Beyotime, China). Equal amounts of protein (10 µg) from each sample were loaded to electrophoresis on a 10% SDS/PAGE gel. Separated protein was transported onto nitrocellulose membrane. The membrane was incubated with antibody against XIAP (1:1000, MBL, Japan) overnight at 4ºC. After washing, the membrane incubated with horseradish peroxidase-conjugated goat anti-mouse IgG before detection using the ECL chemoluminescence system. Membranes were probed for β-actin to normalize for equal protein loading and transfer.
Measurement of mitochondrial membrane potential
Mitochondrial membrane potential (MMP) was measured by the retention of Rhodamine 123 (Rh123), a membrane-permeable fluorescent cationic dye. The uptake of RH123 by mitochondria is proportional to the MMP. Briefly, cells were adjusted to a density of 106/mL in PBS. 150 µL Rh123 (1 µg/mL, Sigma, USA) was added to 150 µL of the cell suspension while 150 µL PBS was added to another 150 µL cell suspension as a negative control. The cell suspensions were incubated at 37ºC for 30 min, and then cells were washed with PBS and analyzed by flow cytometry. The relative fluorescence intensity (RFI) was determined by: [MFI (mean fluorescence intensity) of the stained group] / [MFI of the unstained group]
All data were expressed as mean ± SD. Statistical analyses were processed with SPSS 11.5 statistical software program. Student's t test was performed between EBV-infected DCs and mock-infected DCs. Significant differences were indicated as *p < 0.05 and **p < 0.01.
Surface molecule expressions on CBDC stimulated with EBV
Immunophenotypic studies were performed on CBDC generated from purified monocytes cultured with IL-4 and GM-CSF. After 7 days of culture, the cells exhibited characteristic DCs morphology and surface molecule expressions. Flow cytometric analysis identified DCs as CD11c+, CD1a+, CD14- cells (Fig. 1). They did not express monocyte surface maker, CD14, indicating that monocytes were induced to DCs. After EBV treatment, CD14 expression did not decrease completely. A lower percentage of CD1a+ cells, a marker of immature monocyte-derived DCs, was generated from the EBV-treated group. There was no difference in the percentages of CD11c+ cells generated from control and EBV-treated groups. The percentage of mannose receptor (MR)-positive cells in EBV-treated DCs was also significantly lower than that in cord blood DCs. However, CD40, CD83 and CD86 on the EBV-treated group could be up-regulated markedly (Fig. 2).
EBV induced CBDC apoptosis
To investigate the apoptotic rate of EBV induced apoptosis, CBDC were double stained with Annexin V and PI at the indicated time. As shown in Fig. 3, the stained cells were divided into three groups: cells in the AV-/PI- subgroup were intact cells; cells in the AV+/PI- subgroup were apoptotic cells; cells in the AV+/PI+ subgroup were necrotic cells. No significant changes were observed in the control group at days 5, 6, and 7. In contrast, EBV treatment led to a slight but significant increase in apoptotic incidences on day 6 after infection, specifically enhancing DC apoptosis in a time-dependent manner. There was no significant difference in the percentage of AV+/PI+ double positive cells between the control and the EBV-treated groups.
EBV-induced nuclear condensation and DNA fragmentation
Cells undergoing apoptosis show a sequence of morphological features, such as chromatin condensation and DNA fragmentation. Chromatin condensation of apoptotic cells was detected by Hoechst 33258 staining. After 7 days of culture, the two groups had a homogeneous pattern of staining for Hoechst 33258. The nuclei of control group appeared with regular contours and were round or ellipse in shape. In contrast, many cells with smaller nuclei and condensed chromatin were observed in EBV-treated group (Fig. 4). DNA fragmentation was detected by TUNEL staining. Many yellowish green TUNEL-positive cells were observed in EBV-treated group (Fig. 4), while very few TUNEL-positive cells were observed in the control group. These data show that EBV induced monocytes derived DCs death in apoptotic way.
Caspases activation in EBV-mediated apoptosis
Caspases, a family of cysteine proteases, play an important role in the execution phase of apoptosis. To assess the activation of caspase 3, 8, 9 in EBV-mediated apoptosis, cells were treated with EBV for up to 7 days. Whole cell extracts were obtained on days 5, 6, and 7. The activation of caspase 3, 8, 9 in EBV-treated group were similar to control group at day 5. Whereas, caspase 3, 8, 9 activity was increased progressively during the following days. No such cleavage was observed in the control cells (Fig. 5). These data indicate that activation of caspase family of proteases was, at least in part, associated with EBV-induced apoptosis.
Down-regulation of XIAP expression
To further confirm that caspases were activated in EBV-induced apoptosis, we assessed XIAP expression. DCs were treated with EBV for up to 7 days. XIAP level was analyzed by Western blotting. As shown in Fig. 6, XIAP was markedly decreased in EBV treated group compared to control cells.
Mitochondrial alterations in EBV-induced apoptosis
Changes in the membrane potential of mitochondria occur in the early phase of apoptosis. To examine the role of mitochondria in EBV-mediated apoptosis, MMP was monitored by mitochondria sensitive dye, Rh123, and analyzed by flow cytometry. As shown in Fig. 7, mitochondria of untreated control cells retained the ability to take up Rh123. However, the MMP of DCs derived from EBV-treated monocytes significantly decreased from day 5 to day 7 in a time-dependent manner.
Despite the fact that monocytes/DCs constitute the key elements in nonspecific and specific immune defenses against viral infection, very little is known about the interactions of EBV with these cell types. Few studies of human neonatal DCs in umbilical cord blood have shown them to be immunocompetent as they can stimulate a mixed leukocyte reaction, although these responses tend to be reduced when compared with adult peripheral blood DCs.5 We have previously demonstrated that CB monocytes can be infected by EBV as shown by the expression of EA and VCA and BcLF-1, BALF-2, and LMP1 mRNA expression (data not shown). Our results suggested that EBV infection could alter biological functions of cord blood monocytes and affect development to CBDC, which might be a new mechanism to disrupt the immune response and promote viral propagation during the early stages of infection.
It is different in susceptibility to EBV treatment between monocytes and DCs, indicating phenotypical alterations during monocyte differentiation into DCs. Immature DCs can be identified by their expression of HLA class I and II molecules, CD1a, CD40, CD80 and CD86, but not CD83. Mature DCs express CD83 and have enhanced HLA class I and II, CD80 and CD86. Some researchers have introduced semi-mature DCs and pathogen-driven regulatory mature DCs. The characteristics of semi-mature DCs are high expression of co-stimulatory molecules and CCR7, low excretion of cytokines, which have been related to immune tolerance and homeostasis.6 The characteristics of pathogen-driven regulatory mature DCs are high expression of co-stimulatory molecules and CCR7, down-regulation of IL-12 secretion and up-regulation of IL-10 secretion, which have been related to protection of host and immune evasion of pathogens.7-12 According to the phenotype, EBV-infected DCs in our culture system were similar to the two kinds of DCs mentioned above, which showed mature phenotype and down-regulation of MR expression, with inhibition of differentiation and without enhancement of antigen presenting capacity.
DCs are critical for efficient induction of primary immune responses and inhibition of their function is likely to delay the development of both cellular and humoral specific immunity in EBV-infected individuals. EBV latent membrane protein 1 (LMP-1) protects infected B cells from apoptosis by up regulation of the bcl-2. EBNA-2, another EBV latent protein, can increase the effect of LMP-1 on bcl-2 expression. Bcl-2 is anti-apoptosis protein.13,14 This mechanism does not seem to be used by EBV with regard to DCs, because EBNA-2 protein was not detected in DCs; moreover, expression bcl-2 and bcl-x are likely to be absent in this type. EBV-induced apoptosis of DCs is a complex phenomenon necessitating multiple events. Although enormous strides made in our understanding of cell death, the mechanism by which EBV cause apoptosis is still unknown.
Viral counterattack could lead to immunosuppression. It could be particularly efficient if it targets DCs, which play a pivotal role in both innate and adaptive immune responses. In this study, we investigated whether EBV might induce apoptosis in DCs derived from cord blood monocytes. We dectected apoptotic DCs by staining with Annexin V and PI. Our results demonstrated that EBV could induce CBDC apoptosis. EBV induced DCs apoptosis which was dependent on caspase activation. We also found that caspase 3, 8, and 9, which belong to the class of proteases involved in apoptosis, were activated. Mitochondrial contribution was validated by MMP loss during apoptosis. We also assessed MMP in apoptotic DCs. The loss of MMP in EBV-treated group suggested that mitochondrion might modulate at an early stage the EBV-mediated death signal. Our findings thus suggested that, in addition to the inhibition of DCs maturation, the immunosuppressive effects of DCs are mediated, at least in part, by inducting DCs apoptosis.
There are two distinct pathways of cell death leading to caspase activation, as already reported. Mitochondrial proteins that cause caspase-dependent cell death include cytochrome C (Cyt C), which triggers caspase-9 activation by binding and activating the apoptotic protease activating factor-1 (Apaf-1), and Smac/Diablo, which potentiates caspase activation by binding inhibitor of apoptosis proteins (IAP) and blocking their caspase-inhibitory activity.
Caspase-3 is activated during most apoptotic processes and is believed to be the main executioner caspase.15 Its activation has been shown to be essential for DNA fragmentation as well as chromatin condensation and plasma membrane blebbing. Biochemically, these alterations are associated with the translocation of phosphatidylserine to the outer leaflet of the plasma membrane and the activation of an endonuclease which cleaves genomic DNA into internucleosomal fragments. The conserved IAP family of proteins can potently inhibit the enzymatic activity of active caspases. In mammals, caspase-3, -7 and -9 are subject to inhibition by IAPs. Interestingly, although caspase-9 binds to several IAPs, it is primarily inhibited by XIAP. By contrast, caspase-3 and -7 are inhibited by XIAP and to a lesser extent, by c-IAP1, c-IAP2 and NAIP.16,17 XIAP almost disappeared in EBV-treated group compared to the control group.
Our results suggested the involvement of different pathways for the differential regulation of co-stimulatory molecule expression and apoptosis. DCs maturation and survival are regulated by different signaling pathways, as previously described.18
In this study, we have compared the outcomes of EBV infected and mock-infected monocytes on the development of primary human dendritic cells, important antigen-presenting cells for initiating adaptive immune responses. EBV not only inhibited the maturation of cord blood monocyte-derived DCs but also promoted the apoptosis of CBDC. It might be one strategy that EBV evades host immune responses to establish persistent infection.
This research was supported by grants from National Natural Science Foundation of China (30471620, 81001314); Science and Technology Commission of Shanghai Municipality, China (044119628); PhD Programs Foundation of Ministry of Educa-tion of China (20090073110085); Shanghai Municipal Education Commission, China (08ZZ61); Shanghai Municipal Health Bureau (2007Y76); Pudong New District Social Development Bureau (PW 2008D-6); PhD Programs Foundation of Shanghai Jiao Tong University School of Medicine (BXJ0919).
Conflict of interest
All authors declare to have no conflict of interest.
1. Kawa K. Epstein-Barr virus-associated diseases in humans. Int J Hematol. 2000;71:108-16. [ Links ]
2. Khanna R, Burrows SR, Moss DJ. Immune regulation in Epstein-Barr virus-associated diseases. Microbiol Rev. 1995;59:387-95. [ Links ]
3. Li L, Liu D, Hutt-Fletcher L, et al. Epstein-Barr virus inhibits the development of dendritic cells by promoting apoptosis of their monocyte precursors in the presence of granulocyte macrophage-colony-stimulating factor and interleukin-4. Blood. 2002;99:3725-34. [ Links ]
4. Salek-Ardakani S, Lyons SA, Arrand JR. Epstein-Barr virus promotes human monocyte survival and maturation through a paracrine induction of IFN-γ. J Immunol. 2004;173:321-31. [ Links ]
5. Liu E, Tu W, Law HK, et al. Decreased yield, phenotypic expression and function of immature monocyte-derived dendritic cells in cord blood. Br J Haematol. 2001;113:240-6. [ Links ]
6. Lutz MB, Schuler G. Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol. 2002;23:445-9. [ Links ]
7. McGuirk P, Johnson PA, Ryan EJ, et al. Filamentous hemagglutinin and pertussis toxin from Bordetella pertussis modulate immune responses to unrelated antigens. J Infect Dis. 2000;182:1286-8. [ Links ]
8. Van der Kleij D, Latz E, Brouwers JFHM, et al. A novel host-parasite lipid cross-talk. Schistosomal lyso-phosphatidylserine activates toll-like receptor 2 and affects immune polarization. J Biol Chem. 2002;277:48122-29. [ Links ]
9. McGuirk P, McCann C, Mills KH. Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis. J Exp Med. 2002;195:221-31. [ Links ]
10. Servet-Delprat C, Vidalain P-O, Bausinger H, et al. Measles virus induces abnormal differentiation of CD40 ligand-activated human dendritic cells. J Immunol. 2000;164:1753-60. [ Links ]
11. Schnorr J-Jr, Xanthakos S, Keikavoussi P, et al. Induction of maturation of human blood dendritic cell precursors by measles virus is associated with immunosuppression. Proc Natl Acad Sci USA. 1997;94:5326-31. [ Links ]
12. Marie JC, Kehren J, Trescol-Biémont M-C, et al. Mechanism of measles virus-induced suppression of inflammatory immune responses. Immunity. 2001;14:69-79. [ Links ]
13. Kieff E. Epstein-Barr virus and its replication. In: Fields BN, Knipe DM, Howley PM, eds. Fields Virology. 3rd ed. Philadelphia: Lippincott-Raven, 1996:2343-96 [ Links ]
14. Gregory CD, Dive C, Henderson S. Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis. Nature. 1991;349:612-14. [ Links ]
15. Shi Y. Mechanisms of caspase activation and inhibition during apoptosis. Mol Cell. 2002;9:459-70. [ Links ]
16. Salvesen GS, Duckett CS. IAP proteins: blocking the road to death's door. Nature Rev Mol Cell Biol. 2002;3:401-10. [ Links ]
17. Maier JK, Lahoua Z, Gendron NH, et al. The neuronal apoptosis inhibitory protein is a direct inhibitor of caspases 3 and 7. J Neurosci. 2002;22:2035-43. [ Links ]
18. Rescigno M, Martino M, Sutherland CL, et al. Dendritic cell survival and maturation are regulated by different signaling pathways. J Exp Med. 1998;188:2175-80. [ Links ]
Received 15 April 2011
Accepted 29 May 2011
* Corresponding author at: Department of Clinical Immunology/Department of Nephrology and Rheumatology, Children's Hospital of Shanghai, Shanghai Jiao Tong University, 1400 Beijing Western Road, Shanghai 200040, China E-mail address: email@example.com (Tong-Xin Chen)